Equity Profile

A

Agilent Technologies, Inc.

Health CareLife Sciences Tools & Services$42.2B

Aug26Wed

Pre-Earnings Brief

UpcomingQ3-2026After Close5:00 PM EDT

Company Snapshot

Agilent Technologies, Inc. (A) operates in the health care sector, specifically focusing on life sciences tools and services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and is closely watched by investors.

$1.49

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and increase sales, which is vital for long-term success.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

A Q3-2026 Earnings Preview

Context

Company Snapshot

Agilent Technologies, Inc. (A) operates in the health care sector, specifically focusing on life sciences tools and services. The company plays a crucial role in providing instruments, software, and services for laboratories, which are essential for research and diagnostics in various fields, including pharmaceuticals and environmental testing.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+2.40%

Avg Stock Reaction

+0.42%

Last Quarter Recap

In Q2-2026, Agilent reported an EPS of $1.49, surpassing estimates by 6.20%. The stock reacted positively, gaining 0.66% the following day.

Management Promises & Guidance

Continued investment in R&D to drive innovation.
Focus on expanding market presence in emerging markets.
Commitment to improving operational efficiency.

Expectations

Wall Street Expectations

Overall, investors are cautiously optimistic about Agilent's upcoming earnings report, particularly given its recent EPS beat.

Bull Case

If Agilent can maintain its growth trajectory and deliver strong revenue figures, it may see a significant boost in stock price.

Bear Case

Conversely, if the company fails to meet expectations or shows signs of slowing growth, it could lead to a negative reaction from the market.

Key Metrics to Watch

Earnings Per Share (EPS)

$1.49

EPS is a key indicator of the company's profitability and is closely watched by investors.

Revenue Growth

N/A

Revenue growth reflects the company's ability to expand its market share and increase sales, which is vital for long-term success.

Operating Margin

N/A

Operating margin indicates how efficiently the company is managing its costs relative to its sales, which impacts overall profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q3-2026?

The EPS figure will be a critical indicator of the company's profitability and could significantly influence investor sentiment.

How is Agilent addressing competition in the life sciences sector?

Understanding the company's strategy to maintain or grow its market share amidst competition is vital for assessing future growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Agilent's ability to leverage its recent R&D investments for significant growth this quarter.

Supporting Evidence

Agilent's recent EPS beat suggests strong underlying performance.

The options market is pricing in a larger move than historical averages, indicating potential for a surprise.

Management's commitment to operational efficiency could yield better margins than expected.

Key Risk

If Agilent can demonstrate revenue growth that exceeds expectations, it could challenge the current cautious consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is currently weighing Agilent's ability to sustain its growth and profitability against competitive pressures.

Bull Confirmed If

An EPS of $1.55 or higher would confirm strong profitability and growth.

Bear Confirmed If

An EPS below $1.40 would signal potential issues with profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±8.07%

Historical Avg

±0.5%

Pricing rich

The options market is pricing in a significant move of over 8%, indicating heightened uncertainty or anticipation around the earnings report.

Options are pricing ±8.1% while A has averaged ±0.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

56.2%

Calls (1.0M)P/C Ratio: 1.30Puts (345K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Agilent beats expectations, history suggests the stock could rise by about 0.46%, confirming a positive growth outlook.

In-Line / Cautious

If results are in line but management is cautious, the stock may see muted movement as investors reassess growth prospects.

Miss

If the company misses expectations, history suggests a potential decline of around 0.29%, indicating investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Insights into market share changes in key segments.
3Management's outlook on competitive pressures and pricing strategies.
4Details on R&D investments and their anticipated returns.
5Comments on operational efficiency improvements and cost management.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Sandisk Corporation

Company Snapshot

Agilent Technologies, Inc. (A) operates in the health care sector, specifically focusing on life sciences tools and services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and is closely watched by investors.

$1.49

Revenue Growth

Revenue growth reflects the company's ability to expand its market share and increase sales, which is vital for long-term success.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

A Q3-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+2.40%

Avg Stock Reaction

+0.42%

Last Quarter Recap

In Q2-2026, Agilent reported an EPS of $1.49, surpassing estimates by 6.20%. The stock reacted positively, gaining 0.66% the following day.

Management Promises & Guidance

Continued investment in R&D to drive innovation.
Focus on expanding market presence in emerging markets.
Commitment to improving operational efficiency.

Expectations

Wall Street Expectations

Overall, investors are cautiously optimistic about Agilent's upcoming earnings report, particularly given its recent EPS beat.

Bull Case

If Agilent can maintain its growth trajectory and deliver strong revenue figures, it may see a significant boost in stock price.

Bear Case

Conversely, if the company fails to meet expectations or shows signs of slowing growth, it could lead to a negative reaction from the market.

Key Metrics to Watch

Earnings Per Share (EPS)

$1.49

EPS is a key indicator of the company's profitability and is closely watched by investors.

Revenue Growth

N/A

Revenue growth reflects the company's ability to expand its market share and increase sales, which is vital for long-term success.

Operating Margin

N/A

Operating margin indicates how efficiently the company is managing its costs relative to its sales, which impacts overall profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q3-2026?

The EPS figure will be a critical indicator of the company's profitability and could significantly influence investor sentiment.

How is Agilent addressing competition in the life sciences sector?

Understanding the company's strategy to maintain or grow its market share amidst competition is vital for assessing future growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Agilent's ability to leverage its recent R&D investments for significant growth this quarter.

Supporting Evidence

Agilent's recent EPS beat suggests strong underlying performance.

The options market is pricing in a larger move than historical averages, indicating potential for a surprise.

Management's commitment to operational efficiency could yield better margins than expected.

Key Risk

If Agilent can demonstrate revenue growth that exceeds expectations, it could challenge the current cautious consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is currently weighing Agilent's ability to sustain its growth and profitability against competitive pressures.

Bull Confirmed If

An EPS of $1.55 or higher would confirm strong profitability and growth.

Bear Confirmed If

An EPS below $1.40 would signal potential issues with profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±8.07%

Historical Avg

±0.5%

Pricing rich

The options market is pricing in a significant move of over 8%, indicating heightened uncertainty or anticipation around the earnings report.

Options are pricing ±8.1% while A has averaged ±0.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

56.2%

Calls (1.0M)P/C Ratio: 1.30Puts (345K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Agilent beats expectations, history suggests the stock could rise by about 0.46%, confirming a positive growth outlook.

In-Line / Cautious

If results are in line but management is cautious, the stock may see muted movement as investors reassess growth prospects.

Miss

If the company misses expectations, history suggests a potential decline of around 0.29%, indicating investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Insights into market share changes in key segments.
3Management's outlook on competitive pressures and pricing strategies.
4Details on R&D investments and their anticipated returns.
5Comments on operational efficiency improvements and cost management.